» Articles » PMID: 28338194

LncRNA NEAT1 is Closely Related with Progression of Breast Cancer Via Promoting Proliferation and EMT

Overview
Date 2017 Mar 25
PMID 28338194
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Breast cancer (BC) is one of the most common cancers in females. Abnormal proliferation and metastasis are key reasons that cause mortality in BC patients. More and more evidence showed that lncRNA played an important role in the BC development, but the mechanism was not well established.

Patients And Methods: The expression of lncRNA NEAT1 was detected in 40 BC patients by qRT-PCR technology. MTT and Wound Healing assays were applied to detect the effect of lncRNA NEAT1 in proliferation and metastasis in BC. Western blot was used to detect possible protein, which was regulated by lncRNA NEAT1.

Results: lncRNA NEAT1 was highly expressed in BC tissue, and the expression was also closely related to the tumor size and lymph node metastasis. Survival study also showed that the expression of lncRNA NEAT1 was closely related with prognosis of BC patients. MTT and Wound Healing assays showed that suppression of lncRNA NEAT1 could lead to decreased proliferation and metastasis in BC cell lines. Western blot also showed that β-catenin and N-cad were decreased while E-cad was increased after lncRNA NEAT1 being suppressed.

Conclusions: lncRNA NEAT1 may act as an oncogene in BC, which can promote proliferation and metastasis of BC.

Citing Articles

Genetic associations of polymorphisms with clinicopathologic characteristics of tongue cancer.

Chen K, Chuang C, Lien M, Su C, Chen M, Tsai H Int J Med Sci. 2025; 22(5):1208-1214.

PMID: 40027195 PMC: 11866524. DOI: 10.7150/ijms.103842.


Eugenol inhibits NEAT1 as a ceRNA in pre-cancerous breast lesions.

Liu Y, Zhang G, Ma Y, Ma M, Jiang X Heliyon. 2025; 11(1):e41353.

PMID: 39811361 PMC: 11732537. DOI: 10.1016/j.heliyon.2024.e41353.


The long non-coding RNA NEAT1 contributes to aberrant STAT3 signaling in pancreatic cancer and is regulated by a metalloprotease-disintegrin ADAM8/miR-181a-5p axis.

Gao Y, Zandieh K, Zhao K, Khizanishvili N, Di Fazio P, Yu X Cell Oncol (Dordr). 2024; .

PMID: 39412616 DOI: 10.1007/s13402-024-01001-0.


Advanced Insights into Competitive Endogenous RNAs (ceRNAs) Regulated Pathogenic Mechanisms in Metastatic Triple-Negative Breast Cancer (mTNBC).

Qattan A, Al-Tweigeri T, Suleman K, Alkhayal W, Tulbah A Cancers (Basel). 2024; 16(17).

PMID: 39272915 PMC: 11394539. DOI: 10.3390/cancers16173057.


Unraveling the role of long non-coding RNAs in therapeutic resistance in acute myeloid leukemia: New prospects & challenges.

Sharma S Noncoding RNA Res. 2024; 9(4):1203-1221.

PMID: 39036603 PMC: 11259994. DOI: 10.1016/j.ncrna.2024.05.009.